Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
UCB SA (GB:0NZT)
LSE:0NZT
Holding GB:0NZT?
Track your performance easily
0NZT Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€66.88 - €186.55
Previous Close€182.92
Volume37.15K
Average Volume (3M)45.73K
Market Cap
€34.85B
Enterprise Value€36.60B
Total Cash (Recent Filing)€1.14B
Total Debt (Recent Filing)€2.90B
Price to Earnings (P/E)144.7
Beta0.76
Next Earnings
Feb 27, 2025EPS Estimate
€2.58Last Dividend Ex-Date
Apr 26, 2024Dividend Yield0.54%
Share Statistics
EPS (TTM)1.26
Shares OutstandingN/A
10 Day Avg. Volume20,261
30 Day Avg. Volume45,732
Standard Deviation0.08
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)3.01
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€209.00Price Target Upside14.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
16.00% Mutual Funds
― Other Institutional Investors
77.18% Public Companies and
Individual Investors
0NZT FAQ
What was UCB SA’s price range in the past 12 months?
UCB SA lowest share price was €66.88 and its highest was €186.55 in the past 12 months.
What is UCB SA’s market cap?
Currently, no data Available
When is UCB SA’s upcoming earnings report date?
UCB SA’s upcoming earnings report date is Feb 27, 2025 which is in 93 days.
How were UCB SA’s earnings last quarter?
UCB SA released its earnings results on Jul 25, 2024. The company reported €2.09 earnings per share for the quarter, beating the consensus estimate of €1.762 by €0.328.
Is UCB SA overvalued?
According to Wall Street analysts UCB SA’s price is currently Undervalued.
Does UCB SA pay dividends?
UCB SA pays a Annually dividend of €0.95 which represents an annual dividend yield of 0.54%. See more information on UCB SA dividends here
What is UCB SA’s EPS estimate?
UCB SA’s EPS estimate is €2.58.
How many shares outstanding does UCB SA have?
UCB SA has 194,505,660 shares outstanding.
What happened to UCB SA’s price movement after its last earnings report?
UCB SA reported an EPS of €2.09 in its last earnings report, beating expectations of €1.762. Following the earnings report the stock price went up 1.568%.
Which hedge fund is a major shareholder of UCB SA?
Currently, no hedge funds are holding shares in GB:0NZT
---
UCB SA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
165.77%
12-Months-Change
Fundamentals
Return on Equity
2.67%
Trailing 12-Months
Asset Growth
1.61%
Trailing 12-Months
Company Description
UCB SA
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, both of which have lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Evenity (osteoporosis), and Nayzilam (cluster seizures).
---
0NZT Stock 12 Month Forecast
Average Price Target
€209.00
▲(14.26% Upside)
Technical Analysis
Best Analysts Covering 0NZT
1 Year
1 Year Success Rate
11/11 ratings generated profit
1 Year Average Return
+39.15%
assigned a buy rating 2 months ago
Copying Peter Verdult's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +39.15% per trade.
---